IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a multi-center, open-label, randomized controlled phase III clinical trial in primary diagnosed loco-regionally advanced nasopharyngeal carcinoma (NPC) patients. The purpose of this study is to evaluate the efficacy of induction chemotherapy (IC) combined with low-dose radiation and immune checkpoint inhibitor (ICI) followed by concurrent chemoradiotherapy (CCRT) versus IC+CCRT, and compare the treatment-related adverse events and quality of life in two groups.
Epistemonikos ID: 34908486a0479c4caec29ae60cdde3b257dde3a6
First added on: May 15, 2024